OSI Systems Reports Fiscal 2021 Fourth Quarter and Full Year Financial Results
OSI Systems reported robust financial results for Q4 and fiscal year 2021, with revenues of $332.2 million in Q4, a 20% increase from the previous year. Net income for Q4 reached $25.9 million, or $1.40 per diluted share, compared to $14.0 million the prior year. Despite a 2% revenue decline to $1.147 billion for the fiscal year, non-GAAP net income rose to $97.9 million, or $5.32 per diluted share. The company anticipates revenues between $1.190 billion to $1.225 billion for fiscal 2022.
- Record fourth quarter revenues of $332.2 million, a 20% increase year-over-year.
- Fourth quarter net income of $25.9 million, or $1.40 per diluted share, up from $14.0 million the previous year.
- Non-GAAP net income increased to $97.9 million in fiscal 2021, up from $85.6 million in the prior year.
- Backlog increased to $1.076 billion, up from $861 million year-over-year.
- Strong performance in Security division with 23% year-over-year revenue growth.
- 2% revenue decline for the fiscal year compared to the previous year.
- Net income for fiscal 2021 slightly decreased from $75.3 million to $74.0 million.
OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced financial results for the fourth quarter and fiscal year ended June 30, 2021.
Deepak Chopra, OSI Systems’ Chairman and Chief Executive Officer, said “We are pleased with our performance for fiscal 2021 and for the fourth quarter, as we finished with record fourth quarter revenues and earnings per share driven by outstanding performance in each of our Security and Optoelectronics and Manufacturing divisions. We enter fiscal 2022 with significant backlog and a robust pipeline of opportunities to enable us to continue the positive momentum.”
The Company reported revenues of
For the fiscal year ended June 30, 2021, revenues decreased by
During the three months ended June 30, 2021, the Company's book-to-bill ratio was approximately 1.0. As of June 30, 2021, the Company's backlog was
Mr. Chopra stated, “We are pleased with the fourth quarter performance of the Security division, which reported a
Mr. Chopra further commented, “Our Optoelectronics and Manufacturing division performed exceptionally well and ended the fiscal year with record fourth quarter sales, bookings, and backlog. Fourth quarter revenues increased
Mr. Chopra continued, “Our Healthcare division made significant improvements in fiscal 2021 with
Fiscal Year 2022 Outlook
For fiscal year 2022, the Company anticipates revenues in the range of
The Company’s fiscal 2022 diluted earnings per share guidance is provided on a non-GAAP basis only. The Company does not provide a reconciliation of guidance for non-GAAP diluted EPS to GAAP diluted EPS (the most directly comparable GAAP measure) on a forward-looking basis because the Company is unable to provide a meaningful or accurate compilation of reconciling items and certain information is not available. This is due to the inherent difficulty and complexity in accurately forecasting the timing and amounts of various items included in the calculation of GAAP diluted EPS but excluded in the calculation of non-GAAP diluted EPS, such as acquisition costs and other non-recurring items that have not yet occurred, are out of the Company’s control, or cannot otherwise reasonably be predicted. For the same reasons, the Company is unable to address the significance of unavailable information which may be material and therefore could result in GAAP diluted EPS, the most directly comparable GAAP financial measure, being materially different from projected non-GAAP diluted EPS.
Presentation of Non-GAAP Financial Measures
This earnings release includes a presentation of non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP operating income (loss) by segment and non-GAAP operating margin, all of which are non-GAAP financial measures. The presentation of these non-GAAP figures for the three months and fiscal years ended June 30, 2020 and 2021 is provided to allow for the comparison of the underlying performance of the Company, net of impairment, restructuring and other charges (including certain legal costs), amortization of intangible assets acquired through business acquisitions and non-cash interest expense primarily related to convertible debt, and their associated tax effects, and the impact of discrete income tax items. Although we exclude amortization of acquired intangible assets from our non-GAAP figures, we believe that it is important for investors to understand that revenue generated from such intangibles is included within revenue in determining non-GAAP financial measures of the Company. Management believes that these non-GAAP financial measures provide (i) enhanced insight into the ongoing operations of the Company, (ii) meaningful information regarding the Company’s financial results (excluding amounts management does not view as reflective of ongoing operating results) for purposes of planning, forecasting, and assessing the performance of the Company’s businesses, (iii) a meaningful comparison of financial results of the current period against results of past periods, and (iv) financial results that are generally more comparable to financial results of peer companies than are GAAP figures. Non-GAAP financial measures should not be assessed in isolation or as a substitute for measures of financial performance prepared in accordance with GAAP. These non-GAAP measures may not be the same as measures used by other companies due to possible differences in methods and in the items or events for which adjustments are made.
Reconciliations of GAAP to non-GAAP financial information are provided in the accompanying tables. The financial results calculated in accordance with GAAP and reconciliations from those financial results should be carefully evaluated.
Conference Call Information
The Company will host a conference call and simultaneous webcast beginning at 9:00am PT (12:00pm ET) today to discuss its results for the fourth quarter and fiscal year ended June 30, 2021. To listen, please visit the Investor Relations section of the OSI Systems website, http://investors.osi-systems.com/index.cfm, and follow the link that will be posted on the front page. A replay of the webcast will be available beginning shortly after the conclusion of the conference call until September 1, 2021. The replay can either be accessed through the Company’s website, www.osi-systems.com, or by telephonic replay by calling 1-855-859-2056 and entering the conference call identification number ‘4243009’ when prompted for the replay code.
About OSI Systems
OSI Systems is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications in the homeland security, healthcare, defense and aerospace industries. The Company combines more than 40 years of electronics engineering and manufacturing experience with offices and production facilities in more than a dozen countries to implement a strategy of expansion into selective end-product markets. For more information on OSI Systems or its subsidiary companies, visit www.osi-systems.com. News Filter: OSIS-E
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements relate to the Company's current expectations, beliefs, and projections concerning matters that are not historical facts. Forward-looking statements are not guarantees of future performance and involve uncertainties, risks, assumptions, and contingencies, many of which are outside the Company's control and which may cause actual results to differ materially from those described in or implied by any forward-looking statement. Forward-looking statements include, but are not limited to, information provided regarding expected revenues, earnings, growth, operational performance and impact of the COVID-19 pandemic in fiscal 2022 and beyond. The Company could be exposed to a variety of negative consequences as a result of delays related to the award of domestic and international contracts; failure to secure the renewal of key customer contracts; delays in customer programs; delays in revenue recognition related to the timing of customer acceptance; changes in domestic and foreign government spending and budgetary, procurement and trade policies adverse to the Company's businesses; global economic uncertainty; impact on the Company’s business related to or resulting from the COVID-19 pandemic such as material delays and cancellations of orders or deliveries thereon, supply chain disruptions, plant closures, or other adverse impacts on the Company’s ability to execute business plans; unfavorable currency exchange rate fluctuations; effect of changes in tax legislation; market acceptance of the Company's new and existing technologies, products, and services; the Company's ability to win new business and convert orders received to sales within the fiscal year; enforcement actions in respect of any noncompliance with laws and regulations, including export control and environmental regulations and the matters that are the subject of some or all of the Company's investigations and compliance reviews; contract and regulatory compliance matters, and actions which, if brought, could result in judgments, settlements, fines, injunctions, debarment, or penalties; and other risks and uncertainties, including, but not limited to, those detailed herein and from time to time in the Company's Securities and Exchange Commission filings, which could have a material and adverse impact on the Company's business, financial condition, and results of operations. Many of the referenced risks could be amplified by the magnitude and duration of the COVID-19 pandemic. For additional information on these and other factors that could cause the Company's future results to differ materially from those in any forward-looking statements, see the section titled "Risk Factors" in the Company's most recently filed Annual Report on Form 10-K and other risks described therein and in documents subsequently filed by the Company from time to time with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements, which are based on currently available information and speak only as of the date on which they are made. The Company assumes no obligation to update any forward-looking statement made in this press release that becomes untrue because of subsequent events, new information, or otherwise, except to the extent it is required to do so under federal securities laws.
OSI SYSTEMS, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data) |
||||||||||||||||
|
|
|
|
|
||||||||||||
|
|
Three Months Ended June 30, |
|
Fiscal Year Ended June 30, |
||||||||||||
|
|
|
2020 |
|
|
|
2021 |
|
|
|
2020 |
|
|
|
2021 |
|
Net revenues: |
|
|
|
|
|
|
|
|||||||||
Products |
$ |
203,688 |
|
|
$ |
264,571 |
|
|
$ |
850,478 |
|
|
$ |
872,809 |
|
|
Services |
|
73,279 |
|
|
|
67,627 |
|
|
|
315,566 |
|
|
|
274,093 |
|
|
Total net revenues |
|
276,967 |
|
|
|
332,198 |
|
|
|
1,166,044 |
|
|
|
1,146,902 |
|
|
Cost of goods sold: |
|
|
|
|
|
|
|
|||||||||
Products |
|
139,222 |
|
|
|
177,243 |
|
|
|
575,342 |
|
|
|
586,935 |
|
|
Services |
|
36,197 |
|
|
|
36,888 |
|
|
|
170,063 |
|
|
|
140,049 |
|
|
Total cost of goods sold |
|
175,419 |
|
|
|
214,131 |
|
|
|
745,405 |
|
|
|
726,984 |
|
|
Gross profit |
|
101,548 |
|
|
|
118,067 |
|
|
|
420,639 |
|
|
|
419,918 |
|
|
Operating expenses: |
|
|
|
|
|
|
|
|||||||||
Selling, general and administrative |
|
60,306 |
|
|
|
68,123 |
|
|
|
251,961 |
|
|
|
240,747 |
|
|
Research and development |
|
12,823 |
|
|
|
13,898 |
|
|
|
57,308 |
|
|
|
53,696 |
|
|
Impairment, restructuring and other charges, net |
|
4,963 |
|
|
|
2,192 |
|
|
|
6,483 |
|
|
|
10,104 |
|
|
Total operating expenses |
|
78,092 |
|
|
|
84,213 |
|
|
|
315,752 |
|
|
|
304,547 |
|
|
Income from operations |
|
23,456 |
|
|
|
33,854 |
|
|
|
104,887 |
|
|
|
115,371 |
|
|
Interest and other expense, net |
|
(4,479 |
) |
|
|
(4,142 |
) |
|
|
(18,765 |
) |
|
|
(16,731 |
) |
|
Income before income taxes |
|
18,977 |
|
|
|
29,712 |
|
|
|
86,122 |
|
|
|
98,640 |
|
|
Provision for income taxes |
|
(5,012 |
) |
|
|
(3,818 |
) |
|
|
(10,870 |
) |
|
|
(24,591 |
) |
|
Net income |
$ |
13,965 |
|
|
$ |
25,894 |
|
|
$ |
75,252 |
|
|
$ |
74,049 |
|
|
|
|
|
|
|
|
|
|
|||||||||
Diluted earnings per share |
$ |
0.76 |
|
|
$ |
1.40 |
|
|
$ |
4.05 |
|
|
$ |
4.03 |
|
|
Weighted average shares outstanding – diluted |
|
18,328 |
|
|
|
18,471 |
|
|
|
18,600 |
|
|
|
18,388 |
|
UNAUDITED SEGMENT INFORMATION (in thousands) |
||||||||||||||||
|
|
|
|
|
||||||||||||
|
|
Three Months Ended June 30, |
|
Fiscal Year Ended June 30, |
||||||||||||
|
|
|
2020 |
|
|
|
2021 |
|
|
|
2020 |
|
|
|
2021 |
|
Revenues – by Segment: |
|
|
|
|
|
|
|
|||||||||
Security division |
$ |
163,566 |
|
|
$ |
201,920 |
|
|
$ |
742,043 |
|
|
$ |
633,340 |
|
|
Healthcare division |
|
57,460 |
|
|
|
51,894 |
|
|
|
185,322 |
|
|
|
212,315 |
|
|
Optoelectronics and Manufacturing division (including intersegment revenues) |
|
67,144 |
|
|
|
92,174 |
|
|
|
283,828 |
|
|
|
349,887 |
|
|
Intersegment revenues eliminations |
|
(11,203 |
) |
|
|
(13,790 |
) |
|
|
(45,149 |
) |
|
|
(48,640 |
) |
|
Total |
$ |
276,967 |
|
|
$ |
332,198 |
|
|
$ |
1,166,044 |
|
|
$ |
1,146,902 |
|
|
|
|
|
|
|
|
|
|
|||||||||
Operating income (loss) – by Segment: |
|
|
|
|
|
|
|
|||||||||
Security division |
$ |
16,658 |
|
|
$ |
32,864 |
|
|
$ |
90,063 |
|
|
$ |
85,515 |
|
|
Healthcare division |
|
9,973 |
|
|
|
5,923 |
|
|
|
15,766 |
|
|
|
31,563 |
|
|
Optoelectronics and Manufacturing division |
|
5,470 |
|
|
|
8,827 |
|
|
|
30,566 |
|
|
|
38,465 |
|
|
Corporate |
|
(8,052 |
) |
|
|
(13,874 |
) |
|
|
(31,630 |
) |
|
|
(39,769 |
) |
|
Intersegment eliminations |
|
(593 |
) |
|
|
114 |
|
|
|
122 |
|
|
|
(403 |
) |
|
Total |
$ |
23,456 |
|
|
$ |
33,854 |
|
|
$ |
104,887 |
|
|
$ |
115,371 |
|
OSI SYSTEMS, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) |
||||||
|
June 30, 2020 |
|
June 30, 2021 |
|||
Assets |
|
|
|
|||
|
|
|
|
|||
Cash and cash equivalents |
$ |
76,102 |
|
$ |
80,613 |
|
Accounts receivable, net |
|
269,840 |
|
|
290,653 |
|
Inventories |
|
241,226 |
|
|
294,208 |
|
Other current assets |
|
30,541 |
|
|
43,930 |
|
Total current assets |
|
617,709 |
|
|
709,404 |
|
Property and equipment, net |
|
127,936 |
|
|
118,004 |
|
Goodwill |
|
310,627 |
|
|
320,304 |
|
Intangible assets, net |
|
128,279 |
|
|
127,608 |
|
Other non-current assets |
|
83,990 |
|
|
109,047 |
|
Total Assets |
$ |
1,268,541 |
|
$ |
1,384,367 |
|
|
|
|
|
|||
Liabilities and Stockholders' Equity |
|
|
|
|||
|
|
|
|
|||
Bank lines of credit |
$ |
59,000 |
|
$ |
-- |
|
Current portion of long-term debt |
|
926 |
|
|
846 |
|
Accounts payable and accrued expenses |
|
154,487 |
|
|
210,077 |
|
Other current liabilities |
|
115,688 |
|
|
133,844 |
|
Total current liabilities |
|
330,101 |
|
|
344,767 |
|
Long-term debt |
|
267,072 |
|
|
276,421 |
|
Other long-term liabilities |
|
99,216 |
|
|
123,359 |
|
Total liabilities |
|
696,389 |
|
|
744,547 |
|
Total stockholders’ equity |
|
572,152 |
|
|
639,820 |
|
Total Liabilities and Stockholders’ Equity |
$ |
1,268,541 |
|
$ |
1,384,367 |
RECONCILIATION OF GAAP TO NON-GAAP
|
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
|
Three Months Ended June 30, |
|
Fiscal Year Ended June 30, |
||||||||||||||||||||||||||||
|
|
2020 |
|
2021 |
|
2020 |
|
2021 |
||||||||||||||||||||||||
|
Net income |
|
EPS |
|
Net income |
|
EPS |
|
Net income |
|
EPS |
|
Net income |
|
EPS |
|||||||||||||||||
GAAP basis |
$ |
13,965 |
|
$ |
0.76 |
|
$ |
25,894 |
|
$ |
1.40 |
|
$ |
75,252 |
|
$ | 4.05 |
$ |
74,049 |
|
$ | 4.03 |
||||||||||
Impairment, restructuring and other charges |
|
4,963 |
|
|
0.27 |
|
|
2,192 |
|
|
0.12 |
|
|
6,483 |
|
0.35 |
|
10,104 |
|
0.55 |
||||||||||||
Amortization of acquired intangible assets |
|
5,550 |
|
|
0.30 |
|
|
4,525 |
|
|
0.25 |
|
|
16,351 |
|
0.88 |
|
15,644 |
|
0.85 |
||||||||||||
Non-cash interest expense |
|
2,157 |
|
|
0.12 |
|
|
2,249 |
|
|
0.12 |
|
|
8,751 |
|
0.47 |
|
8,968 |
|
0.48 |
||||||||||||
Tax effect of above adjustments |
|
(3,582 |
) |
|
(0.20 |
) |
|
(2,346 |
) |
|
(0.13 |
) |
|
(8,623 |
) |
(0.47 |
) |
|
(9,240 |
) |
(0.50 |
) | ||||||||||
Discrete tax items |
|
(603 |
) |
|
(0.03 |
) |
|
(3,983 |
) |
|
(0.22 |
) |
|
(12,640 |
) |
(0.68 |
) |
|
(1,664 |
) |
(0.09 |
) | ||||||||||
Non-GAAP basis |
$ |
22,450 |
|
$ |
1.22 |
|
$ |
28,531 |
|
$ |
1.54 |
|
$ |
85,574 |
|
$ | 4.60 |
$ |
97,861 |
|
$ | 5.32 |
RECONCILIATION OF GAAP TO NON-GAAP OPERATING INCOME (LOSS) AND OPERATING MARGIN BY SEGMENT (in thousands, except percentages) |
||||||||||||||||||||||||||||
Three Months Ended June 30, 2020 |
||||||||||||||||||||||||||||
|
|
Security Division |
|
Healthcare Division |
|
Optoelectronics and Manufacturing Division |
|
Corporate / Elimination |
|
Total |
||||||||||||||||||
|
|
|
|
% of
|
|
|
|
% of
|
|
|
|
% of
|
|
|
|
|
|
% of
|
||||||||||
GAAP basis – operating income (loss) |
|
$ |
16,658 |
|
10.2 |
% |
|
$ |
9,973 |
|
17.4 |
% |
|
$ |
5,470 |
|
8.1 |
% |
|
$ |
(8,645 |
) |
|
$ |
23,456 |
|
8.5 |
% |
Impairment, restructuring and other charges, net |
|
|
4,618 |
|
2.8 |
% |
|
|
- |
|
- |
|
|
|
340 |
|
0.5 |
% |
|
|
5 |
|
|
|
4,963 |
|
1.8 |
% |
Amortization of acquired intangible assets |
|
|
4,142 |
|
2.5 |
% |
|
|
- |
|
- |
|
|
|
1,408 |
|
2.2 |
% |
|
|
- |
|
|
|
5,550 |
|
2.0 |
% |
Non-GAAP basis– operating income (loss) |
|
$ |
25,418 |
|
15.5 |
% |
|
$ |
9,973 |
|
17.4 |
% |
|
$ |
7,218 |
|
10.8 |
% |
|
$ |
(8,640 |
) |
|
$ |
33,969 |
|
12.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Three Months Ended June 30, 2021 |
||||||||||||||||||||||||||||
|
|
Security Division |
|
Healthcare Division |
|
Optoelectronics and Manufacturing Division |
|
Corporate / Elimination |
|
Total |
||||||||||||||||||
|
|
|
|
% of
|
|
|
|
% of
|
|
|
|
% of
|
|
|
|
|
|
% of
|
||||||||||
GAAP basis – operating income (loss) |
|
$ |
32,864 |
|
16.3 |
% |
|
$ |
5,923 |
|
11.4 |
% |
|
$ |
8,827 |
|
9.6 |
% |
|
$ |
(13,760 |
) |
|
$ |
33,854 |
|
10.2 |
% |
Impairment, restructuring and other charges, net |
|
|
374 |
|
0.2 |
% |
|
|
- |
|
- |
|
|
|
169 |
|
0.2 |
% |
|
|
1,649 |
|
|
|
2,192 |
|
0.7 |
% |
Amortization of acquired intangible assets |
|
|
3,151 |
|
1.5 |
% |
|
|
201 |
|
0.4 |
% |
|
|
1,173 |
|
1.2 |
% |
|
|
- |
|
|
|
4,525 |
|
1.3 |
% |
Non-GAAP basis– operating income (loss) |
|
$ |
36,389 |
|
18.0 |
% |
|
$ |
6,124 |
|
11.8 |
% |
|
$ |
10,169 |
|
11.0 |
% |
|
$ |
(12,111 |
) |
|
$ |
40,571 |
|
12.2 |
% |
RECONCILIATION OF GAAP TO NON-GAAP OPERATING INCOME (LOSS) AND OPERATING MARGIN BY SEGMENT (in thousands, except percentages) |
||||||||||||||||||||||||||||
Fiscal Year Ended June 30, 2020 |
||||||||||||||||||||||||||||
|
|
Security Division |
|
Healthcare Division |
|
Optoelectronics and Manufacturing Division |
|
Corporate / Elimination |
|
Total |
||||||||||||||||||
|
|
|
|
% of
|
|
|
|
% of
|
|
|
|
% of
|
|
|
|
|
|
% of
|
||||||||||
GAAP basis – operating income (loss) |
|
$ |
90,063 |
|
12.1 |
% |
|
$ |
15,766 |
|
8.5 |
% |
|
$ |
30,566 |
|
10.8 |
% |
|
$ |
(31,508 |
) |
|
$ |
104,887 |
|
9.0 |
% |
Impairment, restructuring and other charges, net |
|
|
5,489 |
|
0.7 |
% |
|
|
3,724 |
|
2.0 |
% |
|
|
658 |
|
0.2 |
% |
|
|
(3,388 |
) |
|
|
6,483 |
|
0.6 |
% |
Amortization of acquired intangible assets |
|
|
12,533 |
|
1.8 |
% |
|
|
- |
|
- |
|
|
|
3,819 |
|
1.3 |
% |
|
|
- |
|
|
|
16,352 |
|
1.4 |
% |
Non-GAAP basis– operating income (loss) |
|
$ |
108,085 |
|
14.6 |
% |
|
$ |
19,490 |
|
10.5 |
% |
|
$ |
35,043 |
|
12.3 |
% |
|
$ |
(34,896 |
) |
|
$ |
127,722 |
|
11.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Fiscal Year Ended June 30, 2021 |
||||||||||||||||||||||||||||
|
|
Security Division |
|
Healthcare Division |
|
Optoelectronics and Manufacturing Division |
|
Corporate / Elimination |
|
Total |
||||||||||||||||||
|
|
|
|
% of
|
|
|
|
% of
|
|
|
|
% of
|
|
|
|
|
|
% of
|
||||||||||
GAAP basis – operating income (loss) |
|
$ |
85,515 |
|
13.5 |
% |
|
$ |
31,563 |
|
14.9 |
% |
|
$ |
38,465 |
|
11.0 |
% |
|
$ |
(40,172 |
) |
|
$ |
115,371 |
|
10.1 |
% |
Impairment, restructuring and other charges, net |
|
|
9,297 |
|
1.5 |
% |
|
|
27 |
|
0.0 |
% |
|
|
315 |
|
0.1 |
% |
|
|
465 |
|
|
|
10,104 |
|
0.9 |
% |
Amortization of acquired intangible assets |
|
|
11,360 |
|
1.8 |
% |
|
|
806 |
|
0.4 |
% |
|
|
3,478 |
|
1.0 |
% |
|
|
- |
|
|
|
15,644 |
|
1.3 |
% |
Non-GAAP basis– operating income (loss) |
|
$ |
106,172 |
|
16.8 |
% |
|
$ |
32,396 |
|
15.3 |
% |
|
$ |
42,258 |
|
12.1 |
% |
|
$ |
(39,707 |
) |
|
$ |
141,119 |
|
12.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20210818005223/en/
FAQ
What were OSIS's fourth quarter financial results for fiscal 2021?
What is the revenue outlook for OSIS for fiscal year 2022?
How did OSIS perform in the Security division during fiscal 2021?